Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMD”

2,293 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,293 results

Not applicableStudy completedNCT07514559
What this trial is testing

Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

Who this might be right for
Age Related Macular Degeneration (ARMD)Retinal Vein Occlusion (RVO)Diabetic Macular Edema (DME)
Hospital Hietzing 393
Not applicableStudy completedNCT01219205
What this trial is testing

Major and Macular Branched Retinal Venous Occlusion

Who this might be right for
Macular Edema
Hallym University Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT00346866
What this trial is testing

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

Who this might be right for
AMD
Alcon Research 136
Not applicableLooking for participantsNCT03921931
What this trial is testing

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Who this might be right for
Macular Degeneration, DryPrimary Open-angle Glaucoma
Medical University of Vienna 35
Testing effectiveness (Phase 2)Study completedNCT02515942
What this trial is testing

CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Alcon Research 114
Not applicableEnrolling By InvitationNCT07747662
What this trial is testing

Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study

Who this might be right for
Geographic Atrophy
University of Wisconsin, Madison 10
Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Not applicableStudy completedNCT00001733
What this trial is testing

Screening for Studies on Retinovascular Diseases

Who this might be right for
Diabetic RetinopathyMacular DegenerationPathologic Neovascularization+1 more
National Eye Institute (NEI) 2,000
Large-scale testing (Phase 3)Study completedNCT00000145
What this trial is testing

Age-Related Eye Disease Study (AREDS)

Who this might be right for
Macular DegenerationCataractLens Opacities
National Eye Institute (NEI) 4,757
Not applicableStudy completedNCT02805686
What this trial is testing

" En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials

Who this might be right for
Maculopathy
Fondation Ophtalmologique Adolphe de Rothschild 45
Not applicableStudy completedNCT05135195
What this trial is testing

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

Who this might be right for
Visual ImpairmentAge-Related Macular DegenerationDiabetic Retinopathy+1 more
NYU Langone Health 98
Not applicableUnknownNCT01608113
What this trial is testing

Long-term Follow-up of Subfoveal Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Vienna 70
Not applicableUnknownNCT05069675
What this trial is testing

Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment

Who this might be right for
Cystoid Macular Edema
University of Catania 2,000
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Testing effectiveness (Phase 2)Study completedNCT02675465
What this trial is testing

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Who this might be right for
Pompe Disease
Amicus Therapeutics 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537
What this trial is testing

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 168
Testing effectiveness (Phase 2)Study completedNCT03211234
What this trial is testing

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 76
Large-scale testing (Phase 3)UnknownNCT03609307
What this trial is testing

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Large-scale testing (Phase 3)Study completedNCT00158600
What this trial is testing

A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease

Who this might be right for
Pompe Disease (Late-onset)Glycogen Storage Disease Type II (GSD-II)Acid Maltase Deficiency Disease+1 more
Genzyme, a Sanofi Company 90
Next Page